+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Sep 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 140
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
Market Analysis and Insights: Global and United States Bio Pharma Buffer Market
This report focuses on global and United States Bio Pharma Buffer market.
In 2020, the global Bio Pharma Buffer market size was US$ 784 million and it is expected to reach US$ 1277 million by the end of 2027, with a CAGR of 7.2% during 2021-2027. In United States the Bio Pharma Buffer market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Bio Pharma Buffer Scope and Market Size
Bio Pharma Buffer market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bio Pharma Buffer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Bio Pharma Buffer market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.
Segment by Type
Phosphates Type
Acetates Type
TRIS Type
Others
Segment by Application
Research Institution
Pharmaceutical Industry
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
1 Study Coverage
1.1 Bio Pharma Buffer Product Introduction
1.2 Market by Type
1.2.1 Global Bio Pharma Buffer Market Size Growth Rate by Type
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bio Pharma Buffer Market Size Growth Rate by Application
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bio Pharma Buffer Market Size, Estimates and Forecasts
2.1.1 Global Bio Pharma Buffer Revenue 2016-2027
2.1.2 Global Bio Pharma Buffer Sales 2016-2027
2.2 Global Bio Pharma Buffer, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Bio Pharma Buffer Historical Market Size by Region (2016-2021)
2.3.1 Global Bio Pharma Buffer Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Bio Pharma Buffer Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Bio Pharma Buffer Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Bio Pharma Buffer Sales Forecast by Region (2022-2027)
2.4.2 Global Bio Pharma Buffer Revenue Forecast by Region (2022-2027)
3 Global Bio Pharma Buffer Competitor Landscape by Players
3.1 Global Top Bio Pharma Buffer Manufacturers by Sales
3.1.1 Global Bio Pharma Buffer Sales by Manufacturer (2016-2021)
3.1.2 Global Bio Pharma Buffer Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Bio Pharma Buffer Manufacturers by Revenue
3.2.1 Key Bio Pharma Buffer Manufacturers Covered: Ranking by Revenue
3.2.2 Global Bio Pharma Buffer Revenue by Manufacturers (2016-2021)
3.2.3 Global Bio Pharma Buffer Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Bio Pharma Buffer Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Bio Pharma Buffer Revenue in 2020
3.2.6 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Bio Pharma Buffer Price by Manufacturers
3.4 Global Bio Pharma Buffer Manufacturing Base Distribution, Product Types
3.4.1 Bio Pharma Buffer Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bio Pharma Buffer Product Type
3.4.3 Date of International Manufacturers Enter into Bio Pharma Buffer Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Bio Pharma Buffer Market Size by Type (2016-2021)
4.1.1 Global Bio Pharma Buffer Sales by Type (2016-2021)
4.1.2 Global Bio Pharma Buffer Revenue by Type (2016-2021)
4.1.3 Bio Pharma Buffer Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Bio Pharma Buffer Market Size Forecast by Type (2022-2027)
4.2.1 Global Bio Pharma Buffer Sales Forecast by Type (2022-2027)
4.2.2 Global Bio Pharma Buffer Revenue Forecast by Type (2022-2027)
4.2.3 Bio Pharma Buffer Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Bio Pharma Buffer Market Size by Application (2016-2021)
5.1.1 Global Bio Pharma Buffer Sales by Application (2016-2021)
5.1.2 Global Bio Pharma Buffer Revenue by Application (2016-2021)
5.1.3 Bio Pharma Buffer Price by Application (2016-2021)
5.2 Bio Pharma Buffer Market Size Forecast by Application (2022-2027)
5.2.1 Global Bio Pharma Buffer Sales Forecast by Application (2022-2027)
5.2.2 Global Bio Pharma Buffer Revenue Forecast by Application (2022-2027)
5.2.3 Global Bio Pharma Buffer Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Bio Pharma Buffer Market Size YoY Growth 2016-2027
6.1.1 United States Bio Pharma Buffer Sales YoY Growth 2016-2027
6.1.2 United States Bio Pharma Buffer Revenue YoY Growth 2016-2027
6.1.3 United States Bio Pharma Buffer Market Share in Global Market 2016-2027
6.2 United States Bio Pharma Buffer Market Size by Players (International and Local Players)
6.2.1 United States Top Bio Pharma Buffer Players by Sales (2016-2021)
6.2.2 United States Top Bio Pharma Buffer Players by Revenue (2016-2021)
6.3 United States Bio Pharma Buffer Historic Market Review by Type (2016-2021)
6.3.1 United States Bio Pharma Buffer Sales Market Share by Type (2016-2021)
6.3.2 United States Bio Pharma Buffer Revenue Market Share by Type (2016-2021)
6.3.3 United States Bio Pharma Buffer Price by Type (2016-2021)
6.4 United States Bio Pharma Buffer Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Bio Pharma Buffer Sales Forecast by Type (2022-2027)
6.4.2 United States Bio Pharma Buffer Revenue Forecast by Type (2022-2027)
6.4.3 United States Bio Pharma Buffer Price Forecast by Type (2022-2027)
6.5 United States Bio Pharma Buffer Historic Market Review by Application (2016-2021)
6.5.1 United States Bio Pharma Buffer Sales Market Share by Application (2016-2021)
6.5.2 United States Bio Pharma Buffer Revenue Market Share by Application (2016-2021)
6.5.3 United States Bio Pharma Buffer Price by Application (2016-2021)
6.6 United States Bio Pharma Buffer Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Bio Pharma Buffer Sales Forecast by Application (2022-2027)
6.6.2 United States Bio Pharma Buffer Revenue Forecast by Application (2022-2027)
6.6.3 United States Bio Pharma Buffer Price Forecast by Application (2022-2027)
7 North America
7.1 North America Bio Pharma Buffer Market Size YoY Growth 2016-2027
7.2 North America Bio Pharma Buffer Market Facts & Figures by Country
7.2.1 North America Bio Pharma Buffer Sales by Country (2016-2021)
7.2.2 North America Bio Pharma Buffer Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Bio Pharma Buffer Market Size YoY Growth 2016-2027
8.2 Asia Pacific Bio Pharma Buffer Market Facts & Figures by Region
8.2.1 Asia Pacific Bio Pharma Buffer Sales by Region (2016-2021)
8.2.2 Asia Pacific Bio Pharma Buffer Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Bio Pharma Buffer Market Size YoY Growth 2016-2027
9.2 Europe Bio Pharma Buffer Market Facts & Figures by Country
9.2.1 Europe Bio Pharma Buffer Sales by Country (2016-2021)
9.2.2 Europe Bio Pharma Buffer Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Bio Pharma Buffer Market Size YoY Growth 2016-2027
10.2 Latin America Bio Pharma Buffer Market Facts & Figures by Country
10.2.1 Latin America Bio Pharma Buffer Sales by Country (2016-2021)
10.2.2 Latin America Bio Pharma Buffer Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Bio Pharma Buffer Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Bio Pharma Buffer Market Facts & Figures by Country
11.2.1 Middle East and Africa Bio Pharma Buffer Sales by Country (2016-2021)
11.2.2 Middle East and Africa Bio Pharma Buffer Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Avantor
12.1.1 Avantor Corporation Information
12.1.2 Avantor Description and Business Overview
12.1.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Avantor Bio Pharma Buffer Products Offered
12.1.5 Avantor Recent Development
12.2 Alfa Aesar (Thermo Fisher)
12.2.1 Alfa Aesar (Thermo Fisher) Corporation Information
12.2.2 Alfa Aesar (Thermo Fisher) Description and Business Overview
12.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Products Offered
12.2.5 Alfa Aesar (Thermo Fisher) Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Bio Pharma Buffer Products Offered
12.3.5 Merck Recent Development
12.4 Lonza
12.4.1 Lonza Corporation Information
12.4.2 Lonza Description and Business Overview
12.4.3 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lonza Bio Pharma Buffer Products Offered
12.4.5 Lonza Recent Development
12.5 Bio-Rad
12.5.1 Bio-Rad Corporation Information
12.5.2 Bio-Rad Description and Business Overview
12.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bio-Rad Bio Pharma Buffer Products Offered
12.5.5 Bio-Rad Recent Development
12.6 BD
12.6.1 BD Corporation Information
12.6.2 BD Description and Business Overview
12.6.3 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.6.4 BD Bio Pharma Buffer Products Offered
12.6.5 BD Recent Development
12.7 GE Healthcare
12.7.1 GE Healthcare Corporation Information
12.7.2 GE Healthcare Description and Business Overview
12.7.3 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GE Healthcare Bio Pharma Buffer Products Offered
12.7.5 GE Healthcare Recent Development
12.8 Promega Corporation
12.8.1 Promega Corporation Corporation Information
12.8.2 Promega Corporation Description and Business Overview
12.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Promega Corporation Bio Pharma Buffer Products Offered
12.8.5 Promega Corporation Recent Development
12.9 Hamilton Company
12.9.1 Hamilton Company Corporation Information
12.9.2 Hamilton Company Description and Business Overview
12.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hamilton Company Bio Pharma Buffer Products Offered
12.9.5 Hamilton Company Recent Development
12.10 XZL BIO-TECHNOLOGY
12.10.1 XZL BIO-TECHNOLOGY Corporation Information
12.10.2 XZL BIO-TECHNOLOGY Description and Business Overview
12.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Products Offered
12.10.5 XZL BIO-TECHNOLOGY Recent Development
12.11 Avantor
12.11.1 Avantor Corporation Information
12.11.2 Avantor Description and Business Overview
12.11.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Avantor Bio Pharma Buffer Products Offered
12.11.5 Avantor Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Bio Pharma Buffer Industry Trends
13.2 Bio Pharma Buffer Market Drivers
13.3 Bio Pharma Buffer Market Challenges
13.4 Bio Pharma Buffer Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bio Pharma Buffer Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Bio Pharma Buffer Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Phosphates Type
Table 3. Major Manufacturers of Acetates Type
Table 4. Major Manufacturers of TRIS Type
Table 5. Major Manufacturers of Others
Table 6. Global Bio Pharma Buffer Market Size Growth Rate by Application (2021-2027) & (K Liter)
Table 7. Global Bio Pharma Buffer Market Size by Region (K Liter) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Bio Pharma Buffer Sales by Regions (2016-2021) & (K Liter)
Table 9. Global Bio Pharma Buffer Sales Market Share by Regions (2016-2021)
Table 10. Global Bio Pharma Buffer Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Bio Pharma Buffer Sales Forecast by Region (2022-2027) & (K Liter)
Table 12. Global Bio Pharma Buffer Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Bio Pharma Buffer Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Bio Pharma Buffer Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Bio Pharma Buffer Sales by Manufacturers (2016-2021) (K Liter)
Table 16. Global Bio Pharma Buffer Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Bio Pharma Buffer Manufacturers by Revenue (US$ Million) in 2020
Table 18. Bio Pharma Buffer Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Bio Pharma Buffer Revenue Share by Manufacturers (2016-2021)
Table 20. Global Bio Pharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Pharma Buffer as of 2020)
Table 22. Key Manufacturers Bio Pharma Buffer Price (2016-2021) (USD/Liter)
Table 23. Bio Pharma Buffer Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Bio Pharma Buffer Product Type
Table 25. Date of International Manufacturers Enter into Bio Pharma Buffer Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Bio Pharma Buffer Sales by Type (2016-2021) (K Liter)
Table 28. Global Bio Pharma Buffer Sales Share by Type (2016-2021)
Table 29. Global Bio Pharma Buffer Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Bio Pharma Buffer Revenue Share by Type (2016-2021)
Table 31. Bio Pharma Buffer Average Selling Price (ASP) by Type (2016-2021) & (USD/Liter)
Table 32. Global Bio Pharma Buffer Sales Forecast by Type (2022-2027) & (K Liter)
Table 33. Global Bio Pharma Buffer Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Bio Pharma Buffer Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Bio Pharma Buffer Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Bio Pharma Buffer Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Liter)
Table 37. Global Bio Pharma Buffer Sales by Application (2016-2021) (K Liter)
Table 38. Global Bio Pharma Buffer Sales Share by Application (2016-2021)
Table 39. Global Bio Pharma Buffer Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Bio Pharma Buffer Revenue Share by Application (2016-2021)
Table 41. Bio Pharma Buffer Average Selling Price (ASP) by Application (2016-2021) & (USD/Liter)
Table 42. Global Bio Pharma Buffer Sales Forecast by Application (2022-2027) & (K Liter)
Table 43. Global Bio Pharma Buffer Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Bio Pharma Buffer Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Bio Pharma Buffer Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Bio Pharma Buffer Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Liter)
Table 47. United States Bio Pharma Buffer Sales (K Liter) of Key Companies (2016-2021)
Table 48. United States Bio Pharma Buffer Sales Share by Company (2016-2021)
Table 49. United States Bio Pharma Buffer Revenue (US$ Million) by Company (2016-2021)
Table 50. United States Bio Pharma Buffer Revenue Share by Company (2016-2021)
Table 51. United States Bio Pharma Buffer Sales (K Liter) by Type (2016-2021)
Table 52. United States Bio Pharma Buffer Sales Share by Type (2016-2021)
Table 53. United States Bio Pharma Buffer Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States Bio Pharma Buffer Price (USD/Liter) by Type (2016-2021)
Table 55. United States Bio Pharma Buffer Sales (K Liter) by Type (2022-2027)
Table 56. United States Bio Pharma Buffer Sales Share by Type (2022-2027)
Table 57. United States Bio Pharma Buffer Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States Bio Pharma Buffer Revenue Share by Type (2022-2027)
Table 59. United States Bio Pharma Buffer Price (USD/Liter) by Type (2022-2027)
Table 60. United States Bio Pharma Buffer Sales (K Liter) by Application (2016-2021)
Table 61. United States Bio Pharma Buffer Sales Share by Application (2016-2021)
Table 62. United States Bio Pharma Buffer Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. United States Bio Pharma Buffer Price (USD/Liter) by Application (2016-2021)
Table 64. United States Bio Pharma Buffer Sales (K Liter) by Application (2022-2027)
Table 65. United States Bio Pharma Buffer Sales Share by Application (2022-2027)
Table 66. United States Bio Pharma Buffer Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. United States Bio Pharma Buffer Revenue Share by Application (2022-2027)
Table 68. United States Bio Pharma Buffer Price (USD/Liter) by Application (2022-2027)
Table 69. North America Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 70. North America Bio Pharma Buffer Sales Market Share by Country (2016-2021)
Table 71. North America Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Bio Pharma Buffer Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Bio Pharma Buffer Sales by Region (2016-2021) & (K Liter)
Table 74. Asia Pacific Bio Pharma Buffer Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Bio Pharma Buffer Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Bio Pharma Buffer Revenue Market Share by Region (2016-2021)
Table 77. Europe Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 78. Europe Bio Pharma Buffer Sales Market Share by Country (2016-2021)
Table 79. Europe Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Bio Pharma Buffer Revenue Market Share by Country (2016-2021)
Table 81. Latin America Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 82. Latin America Bio Pharma Buffer Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Bio Pharma Buffer Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 86. Middle East and Africa Bio Pharma Buffer Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Bio Pharma Buffer Revenue Market Share by Country (2016-2021)
Table 89. Avantor Corporation Information
Table 90. Avantor Description and Business Overview
Table 91. Avantor Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 92. Avantor Bio Pharma Buffer Product
Table 93. Avantor Recent Development
Table 94. Alfa Aesar (Thermo Fisher) Corporation Information
Table 95. Alfa Aesar (Thermo Fisher) Description and Business Overview
Table 96. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 97. Alfa Aesar (Thermo Fisher) Product
Table 98. Alfa Aesar (Thermo Fisher) Recent Development
Table 99. Merck Corporation Information
Table 100. Merck Description and Business Overview
Table 101. Merck Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 102. Merck Product
Table 103. Merck Recent Development
Table 104. Lonza Corporation Information
Table 105. Lonza Description and Business Overview
Table 106. Lonza Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 107. Lonza Product
Table 108. Lonza Recent Development
Table 109. Bio-Rad Corporation Information
Table 110. Bio-Rad Description and Business Overview
Table 111. Bio-Rad Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 112. Bio-Rad Product
Table 113. Bio-Rad Recent Development
Table 114. BD Corporation Information
Table 115. BD Description and Business Overview
Table 116. BD Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 117. BD Product
Table 118. BD Recent Development
Table 119. GE Healthcare Corporation Information
Table 120. GE Healthcare Description and Business Overview
Table 121. GE Healthcare Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 122. GE Healthcare Product
Table 123. GE Healthcare Recent Development
Table 124. Promega Corporation Corporation Information
Table 125. Promega Corporation Description and Business Overview
Table 126. Promega Corporation Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 127. Promega Corporation Product
Table 128. Promega Corporation Recent Development
Table 129. Hamilton Company Corporation Information
Table 130. Hamilton Company Description and Business Overview
Table 131. Hamilton Company Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 132. Hamilton Company Product
Table 133. Hamilton Company Recent Development
Table 134. XZL BIO-TECHNOLOGY Corporation Information
Table 135. XZL BIO-TECHNOLOGY Description and Business Overview
Table 136. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 137. XZL BIO-TECHNOLOGY Product
Table 138. XZL BIO-TECHNOLOGY Recent Development
Table 139. SRL Corporation Information
Table 140. SRL Description and Business Overview
Table 141. SRL Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 142. SRL Product
Table 143. SRL Recent Development
Table 144. Bio Pharma Buffer Market Trends
Table 145. Bio Pharma Buffer Market Drivers
Table 146. Bio Pharma Buffer Market Challenges
Table 147. Bio Pharma Buffer Market Restraints
Table 148. Bio Pharma Buffer Customers List
Table 149. Bio Pharma Buffer Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio Pharma Buffer Product Picture
Figure 2. Global Bio Pharma Buffer Sales Market Share by Type in 2020 & 2027
Figure 3. Phosphates Type Product Picture
Figure 4. Acetates Type Product Picture
Figure 5. TRIS Type Product Picture
Figure 6. Others Product Picture
Figure 7. Global Bio Pharma Buffer Sales Market Share by Application in 2020 & 2027
Figure 8. Research Institution
Figure 9. Pharmaceutical Industry
Figure 10. Others
Figure 11. Bio Pharma Buffer Report Years Considered
Figure 12. Global Bio Pharma Buffer Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bio Pharma Buffer Market Size 2016-2027 (US$ Million)
Figure 14. Global Bio Pharma Buffer Sales 2016-2027 (K Liter)
Figure 15. Global Bio Pharma Buffer Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Bio Pharma Buffer Sales Market Share by Region (2016-2021)
Figure 17. Global Bio Pharma Buffer Sales Market Share by Region in 2020
Figure 18. Global Bio Pharma Buffer Revenue Market Share by Region (2016-2021)
Figure 19. Global Bio Pharma Buffer Revenue Market Share by Region in 2020
Figure 20. Global Bio Pharma Buffer Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Bio Pharma Buffer Revenue in 2020
Figure 22. Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Bio Pharma Buffer Sales Market Share by Type (2016-2021)
Figure 24. Global Bio Pharma Buffer Sales Market Share by Type in 2020
Figure 25. Global Bio Pharma Buffer Revenue Market Share by Type (2016-2021)
Figure 26. Global Bio Pharma Buffer Revenue Market Share by Type in 2020
Figure 27. Global Bio Pharma Buffer Sales Market Share by Application (2016-2021)
Figure 28. Global Bio Pharma Buffer Sales Market Share by Application in 2020
Figure 29. Global Bio Pharma Buffer Revenue Market Share by Application (2016-2021)
Figure 30. Global Bio Pharma Buffer Revenue Market Share by Application in 2020
Figure 31. United States Bio Pharma Buffer Sales Growth Rate 2016-2027 (K Liter)
Figure 32. United States Bio Pharma Buffer Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. United States Bio Pharma Buffer Market Share in Global Market 2016-2027
Figure 34. United States 5 and 10 Largest Bio Pharma Buffer Players Market Share by Revenue in Bio Pharma Buffer in 2020
Figure 35. United States Bio Pharma Buffer Revenue Share by Type (2016-2021)
Figure 36. United States Bio Pharma Buffer Revenue Growth Rate by Type in 2016 & 2020
Figure 37. United States Bio Pharma Buffer Revenue Share by Application (2016-2021)
Figure 38. United States Bio Pharma Buffer Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Bio Pharma Buffer Sales Growth Rate 2016-2021 (K Liter)
Figure 40. North America Bio Pharma Buffer Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Bio Pharma Buffer Sales Market Share by Country in 2020
Figure 42. North America Bio Pharma Buffer Revenue Market Share by Country in 2020
Figure 43. U.S. Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 44. U.S. Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 46. Canada Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Bio Pharma Buffer Sales Growth Rate 2016-2021 (K Liter)
Figure 48. Europe Bio Pharma Buffer Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Bio Pharma Buffer Sales Market Share by Country in 2020
Figure 50. Europe Bio Pharma Buffer Revenue Market Share by Country in 2020
Figure 51. Germany Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 52. Germany Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 54. France Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 56. U.K. Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 58. Italy Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 60. Russia Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Bio Pharma Buffer Sales Growth Rate 2016-2021 (K Liter)
Figure 62. Asia Pacific Bio Pharma Buffer Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Bio Pharma Buffer Sales Market Share by Region in 2020
Figure 64. Asia Pacific Bio Pharma Buffer Revenue Market Share by Region in 2020
Figure 65. China Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 66. China Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 68. Japan Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 70. South Korea Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 72. India Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 74. Australia Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 76. Taiwan Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 78. Indonesia Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 80. Thailand Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 82. Malaysia Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 84. Philippines Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 86. Vietnam Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Bio Pharma Buffer Sales Growth Rate 2016-2021 (K Liter)
Figure 88. Latin America Bio Pharma Buffer Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Bio Pharma Buffer Sales Market Share by Country in 2020
Figure 90. Latin America Bio Pharma Buffer Revenue Market Share by Country in 2020
Figure 91. Mexico Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 92. Mexico Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 94. Brazil Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 96. Argentina Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Bio Pharma Buffer Sales Growth Rate 2016-2021 (K Liter)
Figure 98. Middle East and Africa Bio Pharma Buffer Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Bio Pharma Buffer Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Bio Pharma Buffer Revenue Market Share by Country in 2020
Figure 101. Turkey Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 102. Turkey Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 104. Saudi Arabia Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. U.A.E Bio Pharma Buffer Sales Growth Rate (2016-2021) (K Liter)
Figure 106. U.A.E Bio Pharma Buffer Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Bio Pharma Buffer Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
